Cyberonics

Cyberonics, Inc. is a medical technology company with core expertise in neuromodulation. The company develops and markets the Vagus Nerve Stimulation (VNS) Therapy System, which has been FDA-approved for treating refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device to deliver pulsed electrical signals to the vagus nerve. Cyberonics promotes the VNS Therapy System in specific global markets.